Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Omega Protein Corp (OME): Wynnefield Capital Continues to Decrease Its Stake

Page 1 of 14

Nelson Obus Wynnefield Capital recently filed an amended 13D filing with the US Securities and Exchange Commission, in which reports further lowering its stake in Omega Protein Corp (NYSE:OME) to 1.06 million shares, which represent 4.7% of the company’s outstanding stock. Previously, the fund held 1.37 million shares, which accounted for 6.2% of the outstanding stock, according to its last amended 13D filing on the company.

Omega Protein is a food business company that delivers healthy nutritious products across the world, running in two divisions: human nutrition and animal nutrition. Over the past 12 months, the company’s shares have increased by 38.18%. In its last financial report for the second quarter of 2016, Omega Protein disclosed earnings per share of $0.62, topping the analysts’ estimates of $0.48, and revenue of 112.7 million, also beating the estimates of $98.9 million. At the beginning of this month, Wunderlich downgraded its rating on Omega Protein’s stock to ‘Hold’ from ‘Buy’ and raised its price target to $26 from $22, Da Davidson boosted its price target to $26 from $20, with a ‘Neutral’ rating on it, and Pivotal Research boosted its price target to $30 from $25, keeping a ‘Buy’ rating on the stock.

Nelson Obus

According to our database, there were 14 investors bullish on Omega Protein Corp (NYSE:OME) at the end of June, up by 1 from the previous quarter. Some of those hedge funds included Peter Algert and Kevin Coldiron’s Algert Coldiron Investors, with a position worth $874,000, Louis Navellier’s Navellier & Associates, which held a position valued at $284,000, and Gavin Saitowitz and Cisco J. Del Valle’s Springbok Capital.

Among new investors in Omega Protein Corp (NYSE:OME) during the second quarter were Ken Griffin’s Citadel Investment Group, which had $524,000 invested in the company, and Robert B. Gillam’s McKinley Capital Management, which acquired a position valued at $5,000.

Follow Omega Protein Corp (NYSE:OME)
Trade (NYSE:OME) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Wynnefield Partners Small Cap Value 345,566 0 345,566 0 345,566 1.5%
Wynnefield Partners Small Cap Value 577,464 0 577,464 0 577,464 2.6%
Wynnefield Small Cap Value Offshore Fund, Ltd. (No 52,953 0 52,953 0 52,953 0.2%
Wynnefield Capital, Inc. Profit Sharing Money Purchase Plan 85,000 0 85,000 0 85,000 0.4%
Wynnefield Capital Management 923,030 0 923,030 0 923,030 4.1%
Wynnefield Capital, Inc. 13-3688495 52,953 0 52,953 0 52,953 0.2%
Nelson Obus 0 1,060,983 0 1,060,983 1,060,983 4.7%
Joshua Landes 0 1,060,983 0 1,060,983 1,060,983 4.7%

Nelson Obus
Nelson Obus
Wynnefield Capital

Page 1 of 14 – SEC Filing



Washington, D.C. 20549



(Amendment No. 8)

Under the Securities Exchange Act of 1934


(Name of Issuer)


Common Stock, $0.01 par value

(Title of Class of Securities)



(CUSIP Number)

Wynnefield Partners Small Cap Value, L.P.

450 Seventh Avenue, Suite 509

New York, New York 10123

Attention: Mr. Nelson Obus

Copy to:

Jeffrey S. Tullman, Esq.

Kane Kessler, P.C.

1350 Avenue of the Americas, 26th Floor

New York, New York 10019

(212) 541-6222

(Name, Address and Telephone
Number of Person Authorized to Receive Notices and Communications)

August 23, 2016

(Date of Event which requires Filing of
this Statement)

If the filing person has previously filed
a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨

Follow Omega Protein Corp (NYSE:OME)
Trade (NYSE:OME) Now!
Page 1 of 14

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!